These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9214425)

  • 1. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.
    Eberhard OK; Haubitz M; Brunkhorst FM; Kliem V; Koch KM; Brunkhorst R
    Arthritis Rheum; 1997 Jul; 40(7):1250-6. PubMed ID: 9214425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection.
    Brunkhorst R; Eberhardt OK; Haubitz M; Brunkhorst FM
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S199-201. PubMed ID: 18470720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRP levels in autoimmune disease can be specified by measurement of procalcitonin.
    Schwenger V; Sis J; Breitbart A; Andrassy K
    Infection; 1998; 26(5):274-6. PubMed ID: 9795783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum procalcitonin in systemic autoimmune diseases--where are we now?
    Buhaescu I; Yood RA; Izzedine H
    Semin Arthritis Rheum; 2010 Oct; 40(2):176-83. PubMed ID: 20132965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum procalcitonin levels in patients with myeloperoxidase-antineutrophil cytoplasmic antibodies-associated glomerulonephritis.
    Komatsuda A; Omokawa A; Fujiwara T; Sato R; Togashi M; Okuyama S; Sawada KI; Wakui H
    Am J Med Sci; 2012 Feb; 343(2):136-140. PubMed ID: 21817883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
    Sitter T; Schmidt M; Schneider S; Schiffl H
    J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.
    Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N
    Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus.
    Quintana G; Medina YF; Rojas C; Fernandez A; Restrepo JF; Rondon F; Iglesias A
    J Clin Rheumatol; 2008 Jun; 14(3):138-42. PubMed ID: 18525431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases.
    Tamaki K; Kogata Y; Sugiyama D; Nakazawa T; Hatachi S; Kageyama G; Nishimura K; Morinobu A; Kumagai S
    J Rheumatol; 2008 Jan; 35(1):114-9. PubMed ID: 18050369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated procalcitonin levels in active Wegener's granulomatosis.
    Moosig F; Csernok E; Reinhold-Keller E; Schmitt W; Gross WL
    J Rheumatol; 1998 Aug; 25(8):1531-3. PubMed ID: 9712096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma procalcitonin in rheumatic diseases].
    Scirè CA; Caporali R; Perotti C; Montecucco C
    Reumatismo; 2003; 55(2):113-8. PubMed ID: 12874646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?
    Eberhard OK; Langefeld I; Kuse ER; Brunkhorst FM; Kliem V; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
    Clin Transplant; 1998 Jun; 12(3):206-11. PubMed ID: 9642511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum procalcitonin has negative predictive value for bacterial infection in active systemic lupus erythematosus.
    Bador KM; Intan S; Hussin S; Gafor AH
    Lupus; 2012 Oct; 21(11):1172-7. PubMed ID: 22652631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin as an indicator of systemic response to infection in active pulmonary Wegener's granulomacytosis.
    Zycinska K; Wardyn KA; Zielonka TM; Tyszko P; Straburzynski M
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():839-44. PubMed ID: 19218712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of serum procalcitonin measurement in the diagnosis of bacterial infection in patients with systemic autoimmune diseases].
    Takajo I; Yamamoto I; Umeki K; Okayama A
    Rinsho Byori; 2012 Apr; 60(4):294-9. PubMed ID: 22686037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases.
    Scirè CA; Cavagna L; Perotti C; Bruschi E; Caporali R; Montecucco C
    Clin Exp Rheumatol; 2006; 24(2):123-8. PubMed ID: 16762145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus.
    Lanoix JP; Bourgeois AM; Schmidt J; Desblache J; Salle V; Smail A; Mazière JC; Betsou F; Choukroun G; Duhaut P; Ducroix JP
    Lupus; 2011 Feb; 20(2):125-30. PubMed ID: 20937623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review.
    Serio I; Arnaud L; Mathian A; Hausfater P; Amoura Z
    Clin Rheumatol; 2014 Sep; 33(9):1209-15. PubMed ID: 25064130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin.
    Brunkhorst FM; Eberhard OK; Brunkhorst R
    Crit Care Med; 1999 Oct; 27(10):2172-6. PubMed ID: 10548201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients.
    Cheval C; Timsit JF; Garrouste-Orgeas M; Assicot M; De Jonghe B; Misset B; Bohuon C; Carlet J
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S153-8. PubMed ID: 18470711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.